These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 36091694)

  • 1. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
    Sethuraman G; Sharma VK; Pahwa P; Khetan P
    Indian J Dermatol; 2012 May; 57(3):199-200. PubMed ID: 22707771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yan Q; Liu X; Lei H; Liu R; Hu Y
    Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.
    Oshikoya KA; Ogunyinka IA; Ogar CK; Abiola A; Ibrahim A; Oreagba IA
    Ther Adv Drug Saf; 2020; 11():2042098620905998. PubMed ID: 32110375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.
    de Bustros P; Baldea A; Sanford A; Joyce C; Adams W; Bouchard C
    Burns; 2022 Nov; 48(7):1561-1573. PubMed ID: 34924230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of published cases of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of acetaminophen.
    Milosavljević MN; Pejčić AV; Milosavljević JZ
    Cutan Ocul Toxicol; 2021 Sep; 40(3):280-292. PubMed ID: 34152866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.
    Satoh TK; Neulinger MM; Stadler PC; Aoki R; French LE
    J Dermatol; 2024 Jan; 51(1):3-11. PubMed ID: 38031902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
    Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
    Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study.
    Glahn JZ; Almeida MN; Kochen A; Noel O; Stogner V; Hsia HC; Savetamal A
    Burns; 2024 Jul; ():. PubMed ID: 39127578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.
    Ziemer M; Kardaun SH; Liss Y; Mockenhaupt M
    Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N
    Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification.
    McKinley BJ; Allen ME; Michels N
    Eur J Med Res; 2023 Jun; 28(1):188. PubMed ID: 37303053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.